Page last updated: 2024-08-26

lysophosphatidic acid and Adenocarcinoma Of Kidney

lysophosphatidic acid has been researched along with Adenocarcinoma Of Kidney in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Chen, W; Chen, ZH; Feng, ZH; Han, H; Huang, KB; Liu, X; Lu, J; Luo, JH; Pan, YH; Shu, GN; Wei, JH; Yao, HH; Zhang, JX; Zheng, ZS; Zhou, M1
Chhabra, R; Nanjundan, M1
Babaian, KN; Hu, X; Kenney, PA; Lin, X; Maity, T; Merrill, MM; Su, SC; Wood, CG; Yang, SF; Zhang, XY1
Furukawa, S; Handa, H; Hashimoto, A; Hashimoto, S; Mikami, S; Oikawa, T; Okada, Y; Onodera, Y; Oya, M; Sabe, H; Sugino, H; Yoshikawa, A1

Other Studies

4 other study(ies) available for lysophosphatidic acid and Adenocarcinoma Of Kidney

ArticleYear
Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184/GPCPD1/ lysophosphatidic acid axis.
    Cancer letters, 2021, 12-28, Volume: 523

    Topics: Adult; Aged; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Kidney Neoplasms; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Middle Aged; Phospholipases; RNA, Circular; Sunitinib

2021
Lysophosphatidic acid reverses Temsirolimus-induced changes in lipid droplets and mitochondrial networks in renal cancer cells.
    PloS one, 2020, Volume: 15, Issue:6

    Topics: Antineoplastic Agents; Autophagy; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Humans; Hydroxychloroquine; Kidney Neoplasms; Lipid Droplets; Lysophospholipids; Mitochondria; Phosphoric Diester Hydrolases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2020
Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Dec-01, Volume: 19, Issue:23

    Topics: Angiogenesis Inhibitors; Animals; Carcinogenesis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Female; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Kidney Neoplasms; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neoplasm Invasiveness; Phosphoric Diester Hydrolases; Pyrroles; Signal Transduction; Sunitinib; Transcriptome; Tumor Burden; Xenograft Model Antitumor Assays

2013
Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer.
    Nature communications, 2016, Feb-08, Volume: 7

    Topics: ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Adult; Aged; Aged, 80 and over; Amides; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; GTP-Binding Protein alpha Subunits, G12-G13; Guanine Nucleotide Exchange Factors; HEK293 Cells; Humans; Immunohistochemistry; Indoles; Isoxazoles; Kidney Neoplasms; Lysophospholipids; Male; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Nerve Tissue Proteins; Propionates; Pyridines; Pyrroles; Receptors, Lysophosphatidic Acid; Signal Transduction; Sirolimus; Sunitinib; Triazoles

2016